PATLY.AIApplication
15060998 · USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES
Filed 2016-03-04 · Granted · Patent 9970938 (2018-05-15) The official file ↗The patent and its PDF ↗ · Art unit 1628 · Examiner Shirley V Gembeh Easy · CPC G01N 33/57484 · Basilea Pharmaceutica AG · FBT Gibbons LLP
Office actions
2
first was Non-final rejection
RCEs
1
no appeal
To first action
7.4 mo
to disposition 26.3 mo
Statutes raised
101 112
2 actions read